Debt-to-equity collapsed from 2.86 in 2026Q1 to 0.06 in 2026Q2 following a $9B debt repayment, while current ratio improved to 3.08, signaling a robust liquidity position.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 |
|---|
| Total Current Assets | 6.36B | 6.77B | 5.99B | 6.34B | 7.51B | 6.93B | 6.61B | 4.75B | 4.4B | 4.22B | 3.39B | 3.83B | 3.46B | 3.36B | 2.86B | 2.31B | 2.12B |
| Cash & Short-Term Investments | 1.68B | 2.31B | 1.99B | 2.04B | 3.58B | 3.48B | 3.6B | 1.93B | 1.7B | 1.56B | 727M | 1.15B | 882M | 610M | 317M | 79M | 63M |
| Cash Only | 1.48B | 2.31B | 1.99B | 2.04B | 3.58B | 3.48B | 3.6B | 1.93B | 1.6B | 1.56B | 727M | 1.15B | 882M | 610M | 317M | 79M | 63M |
| Short-Term Investments | 200M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 99M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 1.57B | 1.59B | 1.32B | 1.3B | 1.22B | 1.13B | 1.01B | 1.09B | 1.04B | 998M | 913M | 937M | 980M | 1.14B | 900M | 871M | 773M |
| Days Sales Outstanding | 59.52 | 61.3 | 51.9 | 55.71 | 54.89 | 53.18 | 55.39 | 63.32 | 64.92 | 68.64 | 68.18 | 71.77 | 74.75 | 91.07 | 75.76 | 75.1 | 78.77 |
| Inventory | 2.57B | 2.43B | 2.31B | 2.56B | 2.35B | 1.92B | 1.63B | 1.41B | 1.39B | 1.43B | 1.5B | 1.47B | 1.29B | 1.29B | 1.34B | 1.06B | 995M |
| Days Inventory Outstanding | 329.81 | 317.45 | 294.3 | 345.34 | 328.7 | 284.86 | 268.03 | 239.71 | 250.35 | 279.43 | 314.17 | 297.81 | 264.76 | 273.12 | 303.6 | 228.91 | 242.6 |
| Other Current Assets | 535M | 436M | 379M | 436M | 369M | 392M | 368M | 320M | 276M | 228M | 248M | 272M | 314M | 316M | 302M | 298M | 285M |
| Total Non-Current Assets | 8.72B | 8.7B | 8.25B | 7.94B | 7.42B | 6.97B | 7B | 6.8B | 6.38B | 4.37B | 4.26B | 4.08B | 3.12B | 3.2B | 3.4B | 3.4B | 3.17B |
| Property, Plant & Equipment | 4.03B | 3.97B | 3.61B | 3.43B | 2.97B | 2.6B | 2.39B | 2.13B | 1.66B | 1.44B | 1.38B | 1.31B | 1.32B | 1.29B | 1.24B | 1.24B | 1.15B |
| Fixed Asset Turnover | 2.40x | 2.39x | 2.56x | 2.49x | 2.72x | 2.99x | 2.79x | 2.94x | 3.51x | 3.70x | 3.54x | 3.65x | 3.63x | 3.52x | 3.49x | 3.41x | 3.12x |
| Goodwill | 2.77B | 2.77B | 2.72B | 2.76B | 2.75B | 2.68B | 2.69B | 2.59B | 2.52B | 1.51B | 1.48B | 1.46B | 976M | 982M | 985M | 989M | 934M |
| Intangible Assets | 918M | 998M | 1.13B | 1.34B | 1.38B | 1.47B | 1.71B | 1.89B | 2.05B | 1.27B | 1.23B | 1.19B | 727M | 803M | 868M | 928M | 924M |
| Long-Term Investments | 1M | 0 | 30M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 384M | 328M | 220M | 206M | 147M | 111M | 106M | 98M | 94M | 75M | 73M | 49M | 48M | 58M | 88M | 97M | 92M |
| Total Assets | 15.08B | 15.47B | 14.24B | 14.29B | 14.93B | 13.9B | 13.61B | 11.54B | 10.78B | 8.59B | 7.65B | 7.91B | 6.59B | 6.56B | 6.26B | 5.71B | 5.28B |
| Asset Turnover | 0.63x | 0.61x | 0.65x | 0.60x | 0.54x | 0.56x | 0.49x | 0.54x | 0.54x | 0.62x | 0.64x | 0.60x | 0.73x | 0.70x | 0.69x | 0.74x | 0.68x |
| Asset Growth % | 25.85% | 8.64% | -0.34% | -4.28% | 7.37% | 2.14% | 17.88% | 7.13% | 25.52% | 12.25% | -3.34% | 20.11% | 0.46% | 4.73% | 9.65% | 8.08% | - |
| Total Current Liabilities | 2.06B | 2.23B | 3.41B | 1.89B | 3.17B | 1.8B | 2.17B | 1.81B | 1.22B | 1.09B | 1.12B | 1.78B | 1.09B | 1.42B | 1.12B | 843M | 808M |
| Accounts Payable | 452M | 487M | 433M | 411M | 405M | 436M | 457M | 301M | 313M | 261M | 265M | 293M | 290M | 506M | 319M | 214M | 206M |
| Days Payables Outstanding | 61.1 | 63.62 | 55.26 | 55.36 | 56.77 | 64.59 | 75.24 | 51.17 | 56.33 | 51.11 | 55.43 | 59.48 | 59.57 | 106.88 | 72.01 | 46.08 | 50.23 |
| Short-Term Debt | 0 | 53M | 1.35B | 3M | 1.35B | 0 | 604M | 500M | 9M | 0 | 0 | 405M | 7M | 15M | 73M | 0 | 38M |
| Deferred Revenue (Current) | 23M | 11M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.06B | 895M | 566M | 484M | 397M | 459M | 388M | 331M | 300M | 280M | 265M | 297M | 246M | 248M | 701M | 611M | 540M |
| Current Ratio | 3.08x | 3.03x | 1.75x | 3.36x | 2.37x | 3.86x | 3.05x | 2.63x | 3.60x | 3.85x | 3.03x | 2.15x | 3.19x | 2.37x | 2.55x | 2.74x | 2.62x |
| Quick Ratio | 1.84x | 1.94x | 1.08x | 2.00x | 1.63x | 2.79x | 2.30x | 1.85x | 2.46x | 2.55x | 1.69x | 1.33x | 2.00x | 1.46x | 1.35x | 1.48x | 1.39x |
| Cash Conversion Cycle | 328.24 | 315.13 | 290.93 | 345.69 | 326.81 | 273.46 | 248.18 | 251.86 | 258.94 | 296.96 | 326.92 | 310.1 | 279.95 | 257.31 | 307.36 | 257.93 | 271.14 |
| Total Non-Current Liabilities | 9.87B | 9.9B | 6.05B | 7.41B | 7.36B | 7.56B | 7.67B | 7.03B | 7.37B | 5.71B | 5.03B | 5.04B | 4.17B | 4.18B | 1.1B | 1.13B | 1.13B |
| Long-Term Debt | 190M | 9.24B | 5.22B | 6.56B | 6.55B | 6.59B | 6.59B | 5.95B | 6.44B | 4.95B | 4.47B | 4.46B | 3.62B | 3.64B | 509M | 575M | 673M |
| Capital Lease Obligations | 599M | 202M | 174M | 188M | 186M | 151M | 163M | 164M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 538M | 139M | 167M | 146M | 142M | 320M | 378M | 434M | 474M | 380M | 244M | 264M | 277M | 322M | 323M | 311M | 218M |
| Other Non-Current Liabilities | 9.56B | 305M | 494M | 508M | 475M | 496M | 530M | 486M | 452M | 373M | 321M | 314M | 264M | 217M | 266M | 246M | 241M |
| Total Liabilities | 11.93B | 12.14B | 9.47B | 9.29B | 10.52B | 9.36B | 9.84B | 8.84B | 8.59B | 6.8B | 6.15B | 6.82B | 5.25B | 5.6B | 2.22B | 1.98B | 1.94B |
| Total Debt | 190M | 9.49B | 6.74B | 6.75B | 8.09B | 6.74B | 7.36B | 6.61B | 6.45B | 4.95B | 4.47B | 4.87B | 3.63B | 3.66B | 582M | 575M | 711M |
| Net Debt | -1.29B | 7.18B | 4.76B | 4.72B | 4.51B | 3.26B | 3.76B | 4.68B | 4.86B | 3.39B | 3.74B | 3.71B | 2.75B | 3.05B | 265M | 496M | 648M |
| Debt / Equity | 0.06x | 2.85x | 1.41x | 1.35x | 1.84x | 1.48x | 1.95x | 2.44x | 2.95x | 2.77x | 2.98x | 4.46x | 2.72x | 3.80x | 0.14x | 0.15x | 0.21x |
| Debt / EBITDA | 0.05x | 2.32x | 1.73x | 1.90x | 2.38x | 2.07x | 2.72x | 2.72x | 2.95x | 2.52x | 2.72x | 4.26x | 3.53x | 4.15x | 0.55x | 0.65x | 1.44x |
| Net Debt / EBITDA | -0.33x | 1.76x | 1.22x | 1.32x | 1.33x | 1.00x | 1.39x | 1.93x | 2.22x | 1.72x | 2.28x | 3.25x | 2.67x | 3.46x | 0.25x | 0.56x | 1.31x |
| Interest Coverage | 14.39x | 14.74x | 13.95x | 12.38x | 12.21x | 11.54x | 9.02x | 8.44x | 8.97x | 9.71x | 8.40x | 5.40x | 8.01x | 7.09x | 23.90x | 11.94x | 5.81x |
| Total Equity | 3.15B | 3.33B | 4.77B | 4.99B | 4.4B | 4.54B | 3.77B | 2.71B | 2.19B | 1.79B | 1.5B | 1.09B | 1.34B | 962M | 4.04B | 3.74B | 3.34B |
| Equity Growth % | -94.33% | -30.17% | -4.43% | 13.35% | -3.1% | 20.43% | 39.33% | 23.94% | 22.34% | 19.15% | 37.4% | -18.4% | 38.98% | -76.19% | 8.16% | 11.72% | - |
| Book Value per Share | 7.54 | 7.51 | 10.49 | 10.80 | 9.36 | 9.53 | 7.88 | 5.62 | 4.49 | 3.62 | 3.01 | 2.17 | 2.66 | 1.92 | 8.08 | 7.75 | 6.94 |
| Total Shareholders' Equity | 3.15B | 3.33B | 4.77B | 5B | 4.41B | 4.54B | 3.77B | 2.71B | 2.19B | 1.77B | 1.49B | 1.07B | 1.31B | 940M | 4.03B | 3.72B | 3.34B |
| Common Stock | 5M | 5M | 5M | 5M | 5M | 5M | 5M | 5M | 5M | 5M | 5M | 5M | 5M | 5M | 0 | 0 | 0 |
| Retained Earnings | 14.65B | 13.74B | 11.97B | 10.29B | 8.67B | 7.19B | 5.66B | 4.43B | 3.27B | 2.11B | 1.48B | 876M | 709M | 276M | 0 | 0 | 0 |
| Treasury Stock | 0 | -10.69B | -7.45B | -5.6B | -4.54B | -2.95B | -2.23B | -2.04B | -1.49B | -852M | -421M | -203M | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -796M | -834M | -940M | -839M | -817M | -764M | -730M | -726M | -629M | -505M | -598M | -622M | -361M | -219M | -157M | -65M | -74M |
| Minority Interest | 0 | 0 | 0 | -6M | -2M | 1M | 4M | 0 | 0 | 16M | 12M | 23M | 26M | 22M | 15M | 16M | 0 |
Debt refinancing and revenue stagnation
Zoetis' total assets have grown modestly from $14.3B to $15.1B over the past year, while equity dropped sharply in 2026Q2 due to a $9B debt repayment, as per SEC filings.
The balance sheet appears to be transitioning from a leveraged structure to a more conservative one, with total debt plummeting from $9.2B in 2026Q1 to $190M in 2026Q2. This dramatic deleveraging, likely funded by cash and operating cash flows, strengthens the equity base but also reduces financial flexibility. The shift suggests management is prioritizing balance sheet resilience, though the sudden change warrants monitoring for any associated one-time charges or asset sales.
Debt-to-equity ratio fell from 2.86 in 2026Q1 to 0.06 in 2026Q2, as reported in financial statements, indicating a near-complete elimination of debt, a dramatic strategic pivot.
The near-total debt repayment in 2026Q2 appears to be a deliberate deleveraging event, possibly funded by cash reserves and strong operating cash flow. This reduces interest expense and refinancing risk, but also suggests that the company may have had excess cash or sold assets. Investors should monitor whether this is a one-time event or a new capital structure policy, as the previous leverage levels were consistent with a mature, cash-generative business.
PPE net increased from $3.5B to $4.0B over the past year, while goodwill remained flat at $2.8B, as per SEC filings, indicating ongoing investment in tangible assets.
The steady increase in PPE suggests continued capital expenditure in manufacturing or facilities, aligning with the company's industrial nature. Goodwill stability implies no major acquisitions or impairments, which is positive for asset quality. The asset mix remains heavily weighted toward tangible assets, which may provide collateral value but also indicates a capital-intensive business model.
Retained earnings grew to $14.7B in 2026Q2, but total equity fell to $3.1B from $5.1B a year earlier, as reported in financial statements, reflecting aggressive share repurchases.
The decline in equity despite rising retained earnings is a clear sign of substantial share buybacks, which reduce the equity base. This capital allocation strategy boosts EPS but increases financial leverage if debt is used. However, with debt now minimal, the low equity is not a concern for solvency, but it does indicate a preference for returning capital over building a larger equity cushion.
Current ratio improved to 3.08 in 2026Q2 from 1.75 in 2024Q4, with cash at $1.5B, as per financial statements, indicating ample short-term liquidity.
The current ratio has consistently remained above 1.7, and the spike to 3.08 in 2026Q2 suggests a strong liquidity position, even after the debt repayment. Cash levels, while lower than the prior quarter, are still substantial relative to current liabilities. This provides a solid buffer against operational shocks and supports ongoing dividend and buyback programs.
The dramatic deleveraging in 2026Q2, with debt falling to $190M, may be a one-time event that obscures stagnant revenue growth, as per SEC filings, warranting scrutiny of core operations.
While the balance sheet appears healthier, the sudden debt repayment could be financed by asset sales or a strategic shift that may not be sustainable. The lack of deferred revenue and minimal growth in assets suggests limited forward visibility. Investors should question whether the deleveraging is a sign of strength or a response to operational challenges, especially given the prior income statement analysis showing revenue growth of only 0.3%.
Quick answers to the most common questions about buying ZTS stock.
As of 2025, Zoetis Inc. (ZTS) had total assets of $15.47B including $6.77B in current assets.
Zoetis Inc. (ZTS) carries total debt of $9.49B, offset by $2.31B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Zoetis Inc. (ZTS) has total shareholders' equity (book value) of $3.33B ($7.51 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Zoetis Inc. (ZTS) reported a current ratio of 3.03x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.